5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| No statute on record | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DENT, ALANA HARRIS | 1 | 44.6% | +32.4% |
| DAVIS, BRIAN J | 1 | 84.9% | -4.4% |
| PACKARD, BENJAMIN J | 1 | 66.2% | +15.8% |
| KAMM, JUDITH MARIE | 1 | 42.9% | +62.6% |
| AZPURU, CARLOS A | 1 | 83.6% | +10.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18734619 | LIPOSOME ENCAPSULATED AFFINITY DRUG | DENT, ALANA HARRIS | 73d overdue |
| 18018132 | TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS | PACKARD, BENJAMIN J | 36d overdue |
| 17917899 | CAROTENOID SOLUTIONS AND USES THEREOF | AZPURU, CARLOS A | 18d overdue |
| 18018205 | TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS | KAMM, JUDITH MARIE | 26d |
| Art Unit | Apps |
|---|---|
| 1643 | 1 |
| 1614 | 1 |
| 1612 | 1 |
| 1611 | 1 |
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18734619 | LIPOSOME ENCAPSULATED AFFINITY DRUG | DENT, ALANA HARRIS | 1643 | §103 | Final Rejection | 73d overdue | Pending | Jun 05, 2024 |
| 18237151 | GAMMA POLYGLUTAMATED LOMETREXOL AND USES THEREOF | DAVIS, BRIAN J | 1614 | Other | Final Rejection | 12d | Pending | Aug 23, 2023 |
| 18018132 | TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS | PACKARD, BENJAMIN J | 1612 | §103 | Non-Final OA | 36d overdue | Pending | Jan 26, 2023 |
| 18018205 | TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS | KAMM, JUDITH MARIE | 1611 | Other | Non-Final OA | 26d | Pending | Jan 26, 2023 |
| 17917899 | CAROTENOID SOLUTIONS AND USES THEREOF | AZPURU, CARLOS A | 1617 | — | Non-Final OA | 18d overdue | Pending | Oct 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial